152 Chapter 8 Figure 1. Distribution of 20 ESBL-negative CMY-2-positive E.coli isolates according to cefotaxime susceptibility Figure 2. Distribution of 20 ESBL-negative CMY-2- positive ESBL-negative E.coli isolates according to ceftazidime susceptibility Figure 3. Distribution of 20 ESBL-negative CMY-2-positive E.coli isolates according to piperacillin-tazobactam susceptibility.
RkJQdWJsaXNoZXIy MTk4NDMw